October 23, 2016 11:46 PM ET

Health Care Technology

Company Overview of Aegate Limited

Company Overview

Aegate Limited operates a secure authentication and traceability service for the pharmaceutical industry in the United Kingdom, Belgium, Greece, and Italy. It offers AegatePROTECT, a real time authentication check of each supplied pack for recalled, expired, or falsified medicines; AegateREACH, a tool to improve treatment adherence and patient education; and AegateASSURE, which communicates urgent regulatory changes, and practical or scientific messages to the pharmacist's computer terminal at point of dispense. The company was founded in 2003 and is based in London, United Kingdom.

123 Buckingham Palace Road

London,  SW1W 9SR

United Kingdom

Founded in 2003


44 2078 211925


44 1763 268156

Key Executives for Aegate Limited

Chief Executive Officer
Chief Channels and Partner Officer
Managing Director of Aegate Italy
Chief Pharmaceutical Sales Officer
Chief Technology Officer
Compensation as of Fiscal Year 2016.

Aegate Limited Key Developments

Aegate Appoints David Brindley as a Chief Scientific Officer

Aegate appointed Dr. David Brindley to the role of Chief Scientific Officer. Dr. Brindley will be responsible for leading the company's' dedicated Hospital Business Unit. David is an international industrial and research leader in healthcare translation. Specifically, at the intersection of novel therapeutic platforms and supporting their efficacious and rapid deployment utilising e-health technologies. He led the worlds first deployment of a medicines authentication system in secondary care, producing the internationally recognised Good Authentication Practice (GAPTM) guidelines. David leads the development and provision of Aegates services in secondary care, pharmacovigilance, bio-manufacturing and training.

European Medicines Verification Organisation Selects Aegate as Service Provider to Implement Medicines Authentication in Europe

Aegate have been appointed by the European Medicines Verification Organisation (EMVO) as a selected Service Provider for the supply of the Advanced National Blueprint Service. Aegate's National Blueprint Service will ensure an end-to-end national system of medicines authentication at point of dispense, ensuring patient safety at the last point of the legal pharmaceutical supply chain.

Aegate Appoints Mark Kroes as Chief Pharmaceutical Sales Officer

Aegate announced that Mark Kroes has joined the company as Chief Pharmaceutical Sales Officer. Mark will lead the sales of all value added commercial services to individual pharmaceutical companies. Mark comes to Aegate from Cegedim where he was the Global VP of the Customer Information Unit. He has extensive experience in the sector and joined Cegedim when they acquired his former company, Dendrite.

Similar Private Companies By Industry

Company Name Region
Abacus Devices Limited Europe
Activ4Life Healthcare Technologies Ltd. Europe
Active Needle Technology Ltd. Europe
Actual Analytics Limited Europe
Acuitas Medical Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aegate Limited, please visit www.aegate.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.